Samaplast AG serves as a key partner in the development and industrialization of the innovative FastSkin wound treatment system by mimiX biotherapeutics. The project aims to accelerate and improve the healing of complex chronic wounds. Samaplast played a leading role in design, process development, tooling, and validated ISO-7 cleanroom manufacturing. Thanks to precise processes and close collaboration, a fully manufacturable and regulatory-compliant medical device was achieved within months. This project highlights Samaplast’s expertise as a trusted partner for complex medical technology – from concept to sterilized series production.
